Bibliographic record

Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes

Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso…. New England Journal of Medicine 2017

Document identifier: CEI-BR-043
Series: Bibliographic record
Version: 1.0
Published: 30 Jul 2026
Last reviewed: 30 Jul 2026
Certainty: Not rated

§1Bibliographic record

§1.1Record

Authors: Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF
Title: Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
Source: New England Journal of Medicine
Year: 2017
Volume, issue, pages: 377(13):1228–1239
Digital object identifier: 10.1056/NEJMoa1612917
PubMed identifier: 28910237
Record type: Journal article
Institute identifier: CEI-BR-043

§1.2Institute documents citing this record

Table 1. Documents in the Institute set that cite this record.

Document	Series
Monograph: Exenatide	Compound monograph
Synthesis: Exenatide in type 2 diabetes mellitus: effect on the anchor outcome	Evidence synthesis
Synthesis: Exenatide in atherosclerotic cardiovascular disease and…	Evidence synthesis
Synthesis: Exenatide in type 2 diabetes mellitus: tolerability and…	Evidence synthesis
Synthesis: Exenatide in atherosclerotic cardiovascular disease and…	Evidence synthesis
Synthesis: Exenatide in type 2 diabetes mellitus: durability of effect	Evidence synthesis
Synthesis: Exenatide in atherosclerotic cardiovascular disease and…	Evidence synthesis
7 citing documents.

§1.3Subject tags

exenatide cardiovascular EXSCEL

Compound Evidence Institute · CEI-BR-043 · https://compoundevidence.com/bibliography/holman2017/ · retrieved 30 July 2026